Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

CD200 expression in plasma cells of nonmyeloma immunoproliferative disorders: clinicopathologic features and comparison with plasma cell myeloma.

Olteanu H, Harrington AM, Kroft SH.

Am J Clin Pathol. 2012 Dec;138(6):867-76. doi: 10.1309/AJCP3TQR1TFHHGAS.

PMID:
23161721
[PubMed - indexed for MEDLINE]
Free Article
2.

Time and temperature stability of T-cell subsets evaluated by a dual-platform method.

Olteanu H, Schur BC, Harrington AM, Kroft SH.

Am J Blood Res. 2012;2(2):128-35. Epub 2012 May 25.

PMID:
22762032
[PubMed]
Free PMC Article
3.

Immunophenotypic stability of CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Kroft SH.

Am J Clin Pathol. 2012 Jun;137(6):1013-4. doi: 10.1309/AJCP8TF3WUIWLZHU. No abstract available.

PMID:
22586062
[PubMed - indexed for MEDLINE]
Free Article
4.

A dissection of the CD45/side scatter "blast gate".

Harrington AM, Olteanu H, Kroft SH.

Am J Clin Pathol. 2012 May;137(5):800-4. doi: 10.1309/AJCPN4G1IZPABRLH.

PMID:
22523220
[PubMed - indexed for MEDLINE]
Free Article
5.

Immunophenotypic stability of S├ęzary cells by flow cytometry: usefulness of flow cytometry in assessing response to and guiding alemtuzumab therapy.

Vaughan J, Harrington AM, Hari PN, Kroft SH, Olteanu H.

Am J Clin Pathol. 2012 Mar;137(3):403-11. doi: 10.1309/AJCP7QHH5XASTJPL.

PMID:
22338052
[PubMed - indexed for MEDLINE]
Free Article
6.

Flow cytometric analysis of surface light chain expression patterns in B-cell lymphomas using monoclonal and polyclonal antibodies.

Horna P, Olteanu H, Kroft SH, Harrington AM.

Am J Clin Pathol. 2011 Dec;136(6):954-9. doi: 10.1309/AJCP3C2QZZBPTMLB.

PMID:
22095382
[PubMed - indexed for MEDLINE]
Free Article
7.

Clinicopathologic analysis of the impact of CD23 expression in plasma cell myeloma with t(11;14)(q13;q32).

Buonaccorsi JN, Kroft SH, Harrington AM, VanTuinen P, Olteanu H.

Ann Diagn Pathol. 2011 Dec;15(6):385-8. doi: 10.1016/j.anndiagpath.2011.04.004. Epub 2011 Jul 2.

PMID:
21724429
[PubMed - indexed for MEDLINE]
8.

Case Study Interpretation--Houston: Case 2. Classical Hodgkin lymphoma.

Olteanu H.

Cytometry B Clin Cytom. 2011 Jul-Aug;80(4):258-60. doi: 10.1002/cyto.b.20598. Epub 2011 Jun 2. No abstract available.

PMID:
21638769
[PubMed - indexed for MEDLINE]
Free Article
9.

High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency.

Olteanu H, Harrington AM, George B, Hari PN, Bredeson C, Kroft SH.

Bone Marrow Transplant. 2012 Mar;47(3):399-403. doi: 10.1038/bmt.2011.83. Epub 2011 Apr 11.

PMID:
21478917
[PubMed - indexed for MEDLINE]
10.

The immunophenotypic stability of plasma cell myeloma by flow cytometry.

Spears MD, Olteanu H, Kroft SH, Harrington AM.

Int J Lab Hematol. 2011 Oct;33(5):483-91. doi: 10.1111/j.1751-553X.2011.01317.x. Epub 2011 Apr 7.

PMID:
21470371
[PubMed - indexed for MEDLINE]
11.

The unique immunophenotype of double-hit lymphomas.

Harrington AM, Olteanu H, Kroft SH, Eshoa C.

Am J Clin Pathol. 2011 Apr;135(4):649-50. doi: 10.1309/AJCPL11MAHISIJBQ. No abstract available.

PMID:
21411790
[PubMed - indexed for MEDLINE]
Free Article
12.

CD200 expression in plasma cell myeloma.

Olteanu H, Harrington AM, Hari P, Kroft SH.

Br J Haematol. 2011 May;153(3):408-11. doi: 10.1111/j.1365-2141.2010.08555.x. Epub 2011 Jan 31. No abstract available.

PMID:
21275968
[PubMed - indexed for MEDLINE]
13.

CD23 expression in follicular lymphoma: clinicopathologic correlations.

Olteanu H, Fenske TS, Harrington AM, Szabo A, He P, Kroft SH.

Am J Clin Pathol. 2011 Jan;135(1):46-53. doi: 10.1309/AJCP27YWLIQRAJPW.

PMID:
21173123
[PubMed - indexed for MEDLINE]
Free Article
14.

The specificity of immunophenotypic alterations in blasts in nonacute myeloid disorders.

Harrington A, Olteanu H, Kroft S.

Am J Clin Pathol. 2010 Nov;134(5):749-61. doi: 10.1309/AJCPFNF5MN1GDWKU.

PMID:
20959658
[PubMed - indexed for MEDLINE]
Free Article
15.

Central nervous system Hodgkin lymphoma: case report and review of the literature.

Torgerson S, Olteanu H, Tinguely M, Fenske TS.

J Neurooncol. 2011 Apr;102(2):329-34. doi: 10.1007/s11060-010-0320-8. Epub 2010 Jul 31.

PMID:
20676729
[PubMed - indexed for MEDLINE]
16.

Immunophenotypic stability of T-cell large granular lymphocytic leukaemia by flow cytometry.

Spears MD, Harrington AM, Kroft SH, Olteanu H.

Br J Haematol. 2010 Oct;151(1):97-9. doi: 10.1111/j.1365-2141.2010.08307.x. Epub 2010 Jul 16. No abstract available.

PMID:
20636433
[PubMed - indexed for MEDLINE]
17.

Persistent localized bone marrow aplasia after radiotherapy with preserved peripheral counts: a study of 8 cases.

Harrington AM, Currey A, Olteanu H, Kroft SH.

Ann Diagn Pathol. 2010 Jun;14(3):168-72. doi: 10.1016/j.anndiagpath.2010.02.006.

PMID:
20471561
[PubMed - indexed for MEDLINE]
18.

Efficacy and safety of long-term (>7 year) alemtuzumab therapy for refractory T-cell large granular lymphocytic leukaemia.

Olteanu H, Harrington AM, Ramirez S, Kroft SH, Hari P.

Br J Haematol. 2010 Aug;150(4):480-1. doi: 10.1111/j.1365-2141.2010.08218.x. Epub 2010 Apr 28. No abstract available.

PMID:
20456357
[PubMed - indexed for MEDLINE]
19.

CD8-positive primary cutaneous anaplastic large T-cell lymphoma (PCALCL): case report and review of this unusual variant of PCALCL.

Plaza JA, Ortega P, Lynott J, Mullane M, Kroft S, Olteanu H.

Am J Dermatopathol. 2010 Jul;32(5):489-91. doi: 10.1097/DAD.0b013e3181c57ec2. Review.

PMID:
20442639
[PubMed - indexed for MEDLINE]
20.

Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy.

Olteanu H, Schur BC, Bredeson C, Atallah E, Kroft SH.

Leuk Lymphoma. 2010 Mar;51(3):481-7. doi: 10.3109/10428190903552120. Epub 2010 Feb 8.

PMID:
20141431
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk